China Pharma Inc. (CPHI)
AMEX: CPHI
· Real-Time Price · USD
1.44
-0.02 (-1.37%)
At close: Aug 15, 2025, 3:59 PM
1.43
-0.69%
After-hours: Aug 15, 2025, 04:04 PM EDT
China Pharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 412.69K | 626.88K | 718.69K | 739.34K | 838.88K | 1.42M | 1.37M | 901.91K | 1.17M | 2.03M | 2.09M | 2.24M | 3.71M | 4.86M | 458.83K | 1.75M | 534.53K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | 367.95K | 281.07K | 406.87K | 298.94K | 390.99K | 728.31K | 397.16K | 367K | 656.38K | 450.67K | 492.13K | 374.56K | 457.67K | 744.04K | 494.28K | 473.44K | 614.02K |
Inventory | 1.98M | 2.27M | 2.5M | 2.82M | 3.68M | 3.73M | 3.77M | 3.91M | 3.76M | 2.95M | 2.89M | 3.53M | 3.91M | 3.34M | 3.07M | 2.98M | 3.66M |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 80.41K | 34.77K | 444.64K | 53.04K | 8.67K | -473 | 91.83K | 41.52K | 2.96K | 3.68K |
Total Current Assets | 2.85M | 3.27M | 3.74M | 3.97M | 5.12M | 6M | 5.81M | 5.53M | 6.08M | 5.96M | 5.61M | 6.26M | 8.17M | 9.09M | 4.14M | 5.26M | 4.88M |
Property-Plant & Equipment | 4.4M | 4.53M | 4.96M | 5.5M | 6.15M | 6.82M | 7.51M | 8.1M | 9.04M | 9.61M | 10.09M | 11.12M | 12.3M | 12.97M | 13.45M | 14.08M | 14.36M |
Goodwill & Intangibles | 6.96M | 7.09M | 4.76M | 4.79M | 4.92M | 3.65M | 2.03M | 2.07M | 2.24M | 2.21M | 503.51K | 541.81K | 582.5K | 589.62K | 589.13K | 600.95K | 600.14K |
Total Long-Term Assets | 11.37M | 11.62M | 9.73M | 10.29M | 11.07M | 10.47M | 9.55M | 10.18M | 11.28M | 11.82M | 10.6M | 11.66M | 12.88M | 13.56M | 14.04M | 14.68M | 14.96M |
Total Assets | 14.22M | 14.89M | 13.47M | 14.26M | 16.19M | 16.47M | 15.35M | 15.7M | 17.36M | 17.78M | 16.2M | 17.92M | 21.04M | 22.65M | 18.18M | 19.94M | 19.85M |
Account Payables | 548.26K | 225.11K | 390.24K | 141.04K | 647.83K | 966.42K | 831.3K | 414.08K | 848.91K | 667.08K | 435.61K | 397.54K | 927.35K | 926.75K | 599.7K | 687.05K | 1.11M |
Deferred Revenue | 114.44K | 162.21K | 24.92K | 101.06K | 112.36K | 90.51K | 172.11K | 61.33K | 136.68K | 520.29K | 84.05K | 138.24K | 136.1K | 210.03K | 420.04K | 525.58K | 572.01K |
Short-Term Debt | 2.09M | 2.16M | 2.52M | 2.58M | 2.66M | 3.1M | 3.87M | 7.64M | 8.63M | 8.72M | 10.05M | 5.74M | 6.86M | 7.11M | 7.39M | 7.51M | 6.34M |
Other Current Liabilities | 1.6M | 1.59M | 24K | 20K | 16K | 1.26M | 8K | 375.35K | 363.96K | 372.58K | 361.19K | 349.81K | 338.42K | 327.03K | 404.65K | 397.26K | n/a |
Total Current Liabilities | 5.12M | 5.02M | 4.76M | 4.71M | 5.73M | 6.82M | 7.06M | 10.55M | 11.92M | 12.74M | 12.63M | 8.36M | 9.9M | 10.51M | 10.45M | 12.19M | 11.03M |
Long-Term Debt | 1.39M | 1.39M | 1.43M | 1.4M | 1.41M | 1.41M | 1.39M | n/a | n/a | n/a | n/a | 4.75M | 4.95M | 5.25M | n/a | 325.07K | 852.19K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 2.13M | 2.12M | 2.18M | 2.14M | 2.17M | 2.19M | 2.18M | 804.97K | 764.9K | 754.7K | 740.33K | 5.53M | 5.8M | 6.12M | 875.23K | 1.22M | 1.65M |
Total Liabilities | 7.25M | 7.14M | 6.94M | 6.85M | 7.9M | 9.01M | 9.24M | 11.35M | 12.69M | 13.49M | 13.37M | 13.89M | 15.7M | 16.63M | 11.33M | 13.42M | 12.68M |
Total Debt | 3.51M | 3.59M | 4.01M | 4.06M | 4.17M | 4.63M | 5.39M | 7.79M | 8.65M | 8.76M | 10.11M | 10.57M | 11.92M | 12.49M | 7.54M | 8.01M | 7.22M |
Common Stock | 3.26K | 32.62K | 17.86K | 17.16K | 14.82K | 10.63K | 104.77K | 87.47K | 84.5K | 74.91K | 50.45K | 49.31K | 48.3K | 47.34K | 47.34K | 45.58K | 45.58K |
Retained Earnings | -44.81M | -44.03M | -42.8M | -41.68M | -40.25M | -39.29M | -38.06M | -37.28M | -36.69M | -36.21M | -34.95M | -34.16M | -33.27M | -32.24M | -31.26M | -30.43M | -29.61M |
Comprehensive Income | 11.33M | 11.32M | 11.52M | 11.38M | 11.43M | 11.45M | 11.33M | 11.25M | 11.78M | 11.57M | 11.39M | 11.99M | 12.62M | 12.56M | 12.42M | 12.46M | 12.27M |
Shareholders Equity | 6.97M | 7.75M | 6.53M | 7.41M | 8.29M | 7.45M | 6.11M | 4.35M | 4.67M | 4.29M | 2.83M | 4.02M | 5.34M | 6.02M | 6.85M | 6.52M | 7.17M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |